Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-010333
Filing Date
2020-04-06
Accepted
2020-04-06 19:02:17
Documents
1
Period of Report
2020-04-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4222
  Complete submission text file 0000899243-20-010333.txt   5707
Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Higgins Michael J (Reporting) CIK: 0001478521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36199 | Film No.: 20778042

Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Issuer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations